scispace - formally typeset
C

Ching-Hsuan Tung

Researcher at Cornell University

Publications -  214
Citations -  18737

Ching-Hsuan Tung is an academic researcher from Cornell University. The author has contributed to research in topics: In vivo & Aptamer. The author has an hindex of 65, co-authored 211 publications receiving 17986 citations. Previous affiliations of Ching-Hsuan Tung include Center for Advanced Biotechnology and Medicine & Fox Chase Cancer Center.

Papers
More filters
Journal ArticleDOI

Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells.

TL;DR: A cell labeling approach using short HIV-Tat peptides to derivatize superparamagnetic nanoparticles is developed, which efficiently internalized into hematopoietic and neural progenitor cells in quantities up to 10–30 pg of super paramagnetic iron per cell.
Journal ArticleDOI

In vivo imaging of tumors with protease-activated near-infrared fluorescent probes.

TL;DR: In vivo imaging showed a 12-fold increase in NIRF signal, allowing the detection of tumors with submillimeter-sized diameters, and this strategy can be used to detect such early stage tumors in vivo and to probe for specific enzyme activity.
Journal ArticleDOI

High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates.

TL;DR: A biocompatible, dextran coated superparamagnetic iron oxide particle was derivatized with a peptide sequence from the HIV-tat protein to improve intracellular magnetic labeling of different target cells, and internalized into lymphocytes over 100-fold more efficiently than nonmodified particles.
Journal ArticleDOI

Fluorescence molecular tomography resolves protease activity in vivo

TL;DR: It is demonstrated that enzyme-activatable fluorochromes can be detected with high positional accuracy in deep tissues, that molecular specificities of different beacons towards enzymes can be resolved and that tomography of beacon activation is linearly related to enzyme concentration.
Journal ArticleDOI

In vivo molecular target assessment of matrix metalloproteinase inhibition

TL;DR: Novel, biocompatible near-infrared fluorogenic MMP substrates can be used as activatable reporter probes to sense MMP activity in intact tumors in nude mice and it is shown for the first time that the effect of MMP inhibition can be directly imaged using this approach within hours after initiation of treatment using the potent MMP inhibitor, prinomastat (AG3340).